NASDAQ

Manhattan Associates, Inc. (MANH)

645 Thanks from members

Manhattan Associates (MANH) demonstrates strong operational momentum with Q2 2026 earnings beating expectations and accelerating cloud growth, yet faces lingering valuation concerns regarding its rich earnings multiple and historical deal delays.

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →